CBMG Secures 43 Million Dollar Injection of Capital

2016-02-11T11:05:13-08:00

Cellular Biomedicine Group Announces a $43.13 Million Strategic Investment from Dangdai International Group Co., Limited, a wholly owned Hong Kong Subsidiary of Wuhan Dangdai Science & Technology Industries Group Inc.SHANGHAI, ...